Event Abstract

Botulinum toxin A in the treatment of bladder dysfunction after spinal cord injury: beyond SNAP 25 cleavage

  • 1 Faculty of Medicine, University of Porto, Portugal
  • 2 i3S, Instituto de Investigação e Inovação em Saúde, Portugal

Introduction & Aims Bladder wall injections of botulinum toxin A (BoNT/A) is the gold-standard treatment for neurogenic detrusor overactivity (NDO) (2), leading to long-lasting improvements on bladder function. BoNT/A acts on motor, autonomic and sensory bladder fibres, cleaving the synaptic protein SNAP-25 and impairing vesicle-mediated neurotransmission (2). The mechanisms underlying the enduring effects of the toxin are still mostly unknown (3) but may reflect neuronal injury and stress . Here we evaluated effects of NDO treatment with BoNT/A in neuronal growth patterns and expression of cell stress markers of bladder afferent neurons. Material & Methods Female rats were submitted to T8/T9 largely incomplete spinal cord transection (SCT) or sham surgery. Awake cystometries were performed at baseline, 1 week and 4 weeks after SCT to evaluate the development of urinary dysfunction. At 4 weeks post-SCT, when NDO is typically present, rats received 10 bladder-wall injections of BoNT/A 10U diluted in 50uL of saline. Control rats received only saline. Three days after bladder injections, awake cystometries were performed and rats were euthanized, followed by bladder and DRG L5-S1 collection. Bladders were processed for immunohistochemistry to evaluate the catalytic activity of BoNT/A and DRG were processed for western blotting (n=4/group) to measure levels of cell stress markers and primary cell culture (n=3/group) to evaluate neuronal growth and dendritic branching. Results Four weeks after SCT, rats presented increased bladder pressure and frequent bladder contractions associated with high voided volumes. BoNT/A treatment reduced maximal bladder pressure and frequency of bladder contractions and induced SNAP-25 cleavage in the bladder wall. This was accompanied by upregulation of cellular stress markers, such as ATF3 and PERK. In vitro assays, used to evaluate intrinsic ability of terminal growth, suggested a tendency for reduced dendritic length in BoNT/A-treated SCT rats, but not in control animals. Conclusions Preliminary results suggest that urodynamic improvements following bladder treatment with BoNT/A, known to reflect SNAP-25 cleavage, may indicate the occurrence of metabolic injury in affected bladder afferent neurons. Severity of this neuronal stress could underlie the prolonged duration of the beneficial effects of BoNT/A in SCI-induced bladder dysfunction.

Figure 1

Acknowledgements

Programa Doutoral em Neurociências – Faculdade de Medicina da Universidade do Porto Prémio Melo e Castro Neurociências 2016, Santa Casa da Misericórdia de Lisboa – INSPIReD Raquel Oliveira PhD fellowship: NORTE-08-5369-FSE-000026 - Programas Doutorais, FSE – Fundo Social Europeu – NORTE2020 – Programa Operacional Regional do Norte Sílvia Chambel PhD fellowship: SFRH/BD/135868/2018, FCT- Fundação para a Ciência e Tecnologia

References

(1) L.F. Cooley, S. Kielb, A Review of Botulinum Toxin A for the Treatment of Neurogenic Bladder, PM R, DOI 10.1016/j.pmrj.2018.07.016(2018) (2) A. Coelho, F. Cruz, C.D. Cruz, A. Avelino, Spread of OnabotulinumtoxinA After Bladder Injection. Experimental Study Using the Distribution of Cleaved SNAP-25 as the Marker of the Toxin Action, European urology, 61 (2012) 1178-1184 (3) O. Rossetto, The binding of botulinum neurotoxins to different peripheral neurons, Toxicon : official journal of the International Society on Toxinology, 147 (2018) 27-31.

Keywords: Botulinum Toxin, neurogenic bladder, spinal cord injury, Neuronal sprouting, cellular stress

Conference: XVI Meeting of the Portuguese Society for Neuroscience (SPN2019), Lisboa, Portugal, 30 May - 1 Jun, 2019.

Presentation Type: Poster presentation

Topic: Cellular and Molecular Neurosciences

Citation: Oliveira R, Chambel SS, Cavaleiro H and Cruz CD (2019). Botulinum toxin A in the treatment of bladder dysfunction after spinal cord injury: beyond SNAP 25 cleavage. Front. Cell. Neurosci. Conference Abstract: XVI Meeting of the Portuguese Society for Neuroscience (SPN2019). doi: 10.3389/conf.fncel.2019.01.00011

Copyright: The abstracts in this collection have not been subject to any Frontiers peer review or checks, and are not endorsed by Frontiers. They are made available through the Frontiers publishing platform as a service to conference organizers and presenters.

The copyright in the individual abstracts is owned by the author of each abstract or his/her employer unless otherwise stated.

Each abstract, as well as the collection of abstracts, are published under a Creative Commons CC-BY 4.0 (attribution) licence (https://creativecommons.org/licenses/by/4.0/) and may thus be reproduced, translated, adapted and be the subject of derivative works provided the authors and Frontiers are attributed.

For Frontiers’ terms and conditions please see https://www.frontiersin.org/legal/terms-and-conditions.

Received: 16 Apr 2019; Published Online: 26 Apr 2019.

* Correspondence: Dr. Raquel Oliveira, Faculty of Medicine, University of Porto, Porto, Portugal, raquellmmoliveira@gmail.com

© 2007 - 2019 Frontiers Media S.A. All Rights Reserved